PHrontline Conversations Continue to Support Pulmonary Hypertension, Pulmonary Arterial Hypertension Nurses
The new educational content series for nurses treating patients with pulmonary hypertension and pulmonary arterial hypertension is set to be more unique than other programs.
Contemporary Clinic spoke with Sandee Lombardi, Clinical Nurse Coordinator at the University of California San Diego Medical Center, and Howard Reid, Vice President of Marketing, Pulmonary Hypertension at Janssen, about PHrontline Conversations, the new educational series for nurses treating patients with pulmonary hypertension (PH) and pulmonary arterial hypertension (PAH).
FDA Approves Omalizumab to Reduce Food-Based Allergic Reactions in Adult and Pediatric Patients
February 21st 2024This marks omalizumab’s fourth FDA-approved indication for allergic and inflammatory conditions, such as severe persistent allergic asthma, with its initial approval being in 2003.
